Vectura is a leader in the development of inhaled pharmaceuticals, using ideas, technologies and skills to create products to treat respiratory, neurological and other diseases – rapidly and effectively. Our goal is to improve patients’ lives and generate value for our stakeholders.
Press releases
23 May 2008Vectura Group plc - Directors’ share acquisition
22 May 2008Vectura Group plc - Preliminary Results for the year ended 31 March 2008
15 April 2008Vectura announces positive data with inhaled anti-migraine product
Latest press releases Share price
| 42.75 GBp +0.50 | VEC.L | |
| Market cap GB£ | 133 | |
| Date | 04/07/2008 | |
Share price information Next events
24-25 June 2008Piper Jaffray Conference, London
25-26 June 2008
Jefferies Healthcare Conference, New York
Investor Calendar 




